Concepedia

Publication | Closed Access

Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor

DOI

238

Citations

42

References

2006

Year

Susannah Stanway, Atul Purohit, L. W. Lawrence Woo, S. Sufi, David M. Vigushin, Rebecca Ward, Richard H. Wilson, Frank Z. Stanczyk, Nicola Dobbs, Elena Kulinskaya,
Clinical Cancer Research

Abstract

STX64 is a potent, well-tolerated STS inhibitor. It inhibits STS activity in PBLs and tumor tissues and causes significant decreases in serum concentrations of steroids with estrogenic properties.

References

YearCitations

Page 1